Dove’s new line of body care products was developed to address symptoms often associated with menopause, such as skin dryness and body odor.
The beauty brand Dove has teamed up with gynecologists, menopause experts and dermatologists to develop a new line of products called the Women’s Wellness Range, according to a recent news release. This launch is part of their “Made with TMI” campaign, which aims to lessen the taboo associated with women’s hormonal health.
Released yesterday, the collection includes three body washes and one leave-on balm formulated to address skincare concerns associated with hormonal shifts.
"As an OB/GYN, I have seen so many women in intimate settings, and they still feel they need to censor their personal concerns in conversations because for generations, women have been taught to be quiet about discomfort, to downplay pain and to feel shame around natural parts of their health,” Jessica Shepherd, M.D., OB/GYN and menopause expert and line co-creator, said in the news release. “We're slowly seeing that shift and unlearning many of these traits, but the silence still lingers."
Because the skin is an endocrine organ, it undergoes major changes during menopause, a stage marked by hormonal fluctuations of estrogen and progesterone.
Estrogen specifically increases collagen and elastin production, which keep the skin hydrated and elastic. As a result, a drop in estrogen can lead to skin dryness and thinning. These menopause symptoms often receive less attention than vasomotor symptoms such as hot flashes but still have a negative impact on quality of life.
While hormone replacement therapy (HRT) may be prescribed to women experiencing hot flashes, mood changes and night sweats, HRT is not currently recommended to treat dermatological complaints alone. This belief can be attributed to the results of the 2002 Women’s Health Initiative (WHI) trial, which stated that HRT is linked to an increased risk for certain cancers. These results led to a dramatic decrease in women taking HRT, despite industry experts now questioning the legitimacy of the results.
Almost all (80%) of menopausal women experience vasomotor symptoms such as night sweats and hot flashes, which can lead to increased body odor. The drop in estrogen levels means there are relatively higher levels of testosterone in the body, which can attract more bacteria to sweat, making it smell worse.
Dove is not the only beauty brand taking interest in menopause. Ulta Beauty and Sephora launched menopause categories on their websites in 2022 and 2023.
Celebrities have also taken note. Halle Berry’s wellness platform, Respin, rebranded this year to focus on menopause and perimenopause, offering community support, lifestyle coaching and personalized health plans. Naomi Watts also has released a line of menopause products through her brand Stripes, launched in 2022.
"The Dove Women's Wellness Range is the latest expression of the brand's long-standing commitment to real beauty, real care and real conversations," Ellen Shepard, senior research & development director at Unilever, said in the news release. "By leveraging Unilever's expertise in surfactant science, odor and sweat management and the microbiome, we're turning women's needs into advanced, personalized care."
The full collection is available exclusively on Amazon, with products starting at $19.99.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Research and Funding Essential to Improving Postpartum Hemorrhage Outcomes
August 5th 2025Ways health systems can support care teams treating postpartum hemorrhage and the potential impacts of the Trump administration’s diversity, equity and inclusion (DEI) policies, according to Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at the University of Illinois.
Read More
U.S. Has Highest Maternal Death Rate Among High-Income Countries, Experts Cite Funding Gaps
August 5th 2025The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of federal funding of pregnancy research, according to a review published in JAMA Health Forum.
Read More